Related Experiment Videos
Ductal carcinoma in situ (DCIS): a revised concept
F E Gump1, D L Jicha, L Ozello
1Department of Surgery, Columbia Presbyterian Medical Center, New York, N.Y.
Surgery
|November 1, 1987
Summary
Ductal carcinoma in situ (DCIS) presents unique challenges due to its gross and microscopic nature. Differentiating between these presentations is crucial for guiding rational breast cancer treatment decisions.
Area of Science:
- Oncology
- Pathology
- Breast Cancer Research
Background:
- The concept of in situ lesions was developed to understand the transition from benign to invasive cancer.
- Lobular carcinoma in situ is a microscopic lesion, unlike ductal carcinoma in situ (DCIS).
- DCIS presents diagnostic challenges due to its combined gross and microscopic manifestations, complicating treatment evaluations.
Purpose of the Study:
- To characterize patients with ductal carcinoma in situ (DCIS).
- To identify subgroups within DCIS based on presentation and disease distribution.
- To establish a basis for rational treatment recommendations for DCIS.
Main Methods:
- Analysis of seventy consecutive patients with DCIS treated at the institution.
- Identification of two distinct subgroups of DCIS patients.
- Examination of disease presentation, breast distribution, and lymph node involvement.
Main Results:
- Differentiation between gross and purely microscopic DCIS is feasible.
- Distinct patterns of presentation and distribution were observed between subgroups.
- The findings support the clinical relevance of distinguishing between gross and microscopic DCIS.
Conclusions:
- Distinguishing between gross and microscopic DCIS is clinically achievable.
- This differentiation is essential for formulating evidence-based treatment strategies for DCIS.
- Further characterization of DCIS subtypes will refine patient management and improve outcomes.